RPG Investment Advisory’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
RPG Investment Advisory's NVO Position: Q2 2026 in Review
RPG Investment Advisory increased its Novo Nordisk (NVO) stake by 33% in Q2 2026, buying an estimated $3.7M and bringing the position to 346,673 shares worth $16.6M. The position accounts for 1.71% of the portfolio, ranked #26.
RPG Investment Advisory first reported a position in NVO in Q3 2024 and has held it in 8 quarters since. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- RPG Investment Advisory held 346,673 shares of Novo Nordisk worth $16.6M as of Q2 2026.
- RPG Investment Advisory bought 86,053 Novo Nordisk shares in Q2 2026, an estimated $3.7M.
- Novo Nordisk made up 1.71% of RPG Investment Advisory's portfolio in Q2 2026, its #26 holding.
- RPG Investment Advisory first reported a position in Novo Nordisk in Q3 2024 and has held it in 8 quarters since.
- 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on RPG Investment Advisory's 13F filing for Q2 2026, filed 4 Aug 2026.